Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Tiziana Life Sciences Ltd
0RPCurrent price
0.8 EUR
0 EUR (0.00%)
Last closed
0.93 USD
Company
www.tizianalifesciences.com
ISIN
BMG889121031
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
83 241 480 USD
Yield for 12 month
+36.42 %
1Y
3Y
5Y
10Y
15Y
0RP
Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology in the United States. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It also develops Milciclib (TZLS-201), an orally bioavailable small molecule broad spectrum inhibitor of various cyclin-dependent kinases and Src family; and TZLS-501, a fully human mAb targeting the IL-6 receptor for the treatment of inflammatory and oncology indications. Tiziana Life Sciences Ltd was incorporated in 1998 and is headquartered in London, the United Kingdom. Address: 14/15 Conduit Street, London, United Kingdom, W1S 2XJ
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
3 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
-51 000 USD
Current Quarter
–
Last Quarter
-46 000 USD
Key Figures 0RP
1 year
3 years
5 years
10 years
EBITDA
-17 977 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-58.15 %
PEG Ratio
–
Return On Equity TTM
-140.93 %
Wall Street Target Price
3 USD
Revenue TTM
-3 595 000 USD
Book Value
0.055 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.17 USD
Diluted Eps TTM
-0.17 USD
Most Recent Quarter
II 2023
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics 0RP
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 0RP
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
2499:1000
Payout Ratio
–
Last Split Date
31.07.2020
Dividend Date
–
Stock Valuation 0RP
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-5.9804
Price Book MRQ
15.0364
Financials 0RP
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 0RP
For 52 weeks
0.41 USD
1.74 USD
50 Day MA
1.02 USD
Shares Short Prior Month
99 802
200 Day MA
0.72 USD
Short Ratio
0.74
Shares Short
274 695
Short Percent
0.44 %
BeatStart